Descriptor English: | Rilmenidine | ||||||
Descriptor Spanish: |
Rilmenidina
| ||||||
Descriptor Portuguese: | Rilmenidina | ||||||
Descriptor French: | Rilménidine | ||||||
Entry term(s): |
2-(N-(Dicyclopropylmethyl)amino)oxazoline 2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt Hyperium Oxaminozoline Rilmenidine Phosphate S 3341 S 3341 3 S-3341 S-3341-3 S3341 S33413 |
||||||
Tree number(s): |
D03.383.129.462.778 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077769 | ||||||
Scope note: | Oxazole derivative that acts as an agonist for ALPHA-2 ADRENERGIC RECEPTORS and IMIDAZOLINE RECEPTORS. It is used in the treatment of HYPERTENSION. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antihypertensive Agents Sympatholytics Adrenergic alpha-2 Receptor Agonists |
||||||
Registry Number: | P67IM25ID8 | ||||||
CAS Type 1 Name: | 2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro- | ||||||
Public MeSH Note: | 2019; RILMENIDINE was indexed under OXAZOLES 1981-2018 |
||||||
History Note: | 2019 (1981) |
||||||
DeCS ID: | 57748 | ||||||
Unique ID: | D000077769 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/03 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Rilmenidine
- Preferred
S3341
- Narrower
Hyperium
- Narrower
S-3341-3
- Narrower
Rilmenidine Phosphate
- Narrower
Concept UI |
M0100916 |
Scope note | Oxazole derivative that acts as an agonist for ALPHA-2 ADRENERGIC RECEPTORS and IMIDAZOLINE RECEPTORS. It is used in the treatment of HYPERTENSION. |
Preferred term | Rilmenidine |
Entry term(s) |
2-(N-(Dicyclopropylmethyl)amino)oxazoline Oxaminozoline |
Concept UI |
M0100917 |
Preferred term | S3341 |
Entry term(s) |
S 3341 S-3341 |
Concept UI |
M0475050 |
Preferred term | Hyperium |
Concept UI |
M0100914 |
Preferred term | S-3341-3 |
Entry term(s) |
S 3341 3 S33413 |
Concept UI |
M0100911 |
Preferred term | Rilmenidine Phosphate |
Entry term(s) |
2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey